Cargando…
In vivo T cell tumor therapy with monoclonal antibody directed to the V beta chain of T cell antigen receptor
To test whether antibodies directed to TCR affect T cell tumor growth in vivo, mice were inoculated intravenously with C6VL tumor cells expressing V beta 6 TCR and then treated intraperitoneally with mAb specific for V beta 6 TCR. Administration of anti-V beta 6 antibody prolonged survival of mice b...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189510/ https://www.ncbi.nlm.nih.gov/pubmed/2530299 |
Ejemplares similares
-
Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones
Publicado: (1983) -
Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice
Publicado: (1993) -
Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.
por: Harwerth, I. M., et al.
Publicado: (1993) -
A Novel Human Monoclonal Antibody Directed to a Tumor‐associated Antigen
por: Kudo, Toshio, et al.
Publicado: (1993) -
B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
por: Zhang, Zheng, et al.
Publicado: (2023)